At the same time, the pathogenetic progression of dyslipidemia associated with secondary hypothyroidism may correlate with a decrease in serum concentration of thyroid hormones and an increase in serum concentration of thyroid-stimulating hormone. This evidence concerns the gene TG and metabolic syndrome.